NOVN News

class="">Eight companies went public in the year’s most active week. Three priced above the range and each finished above its IPO price (average return of 38%). Biotech Novan and ad-tech platform The Trade Desk led the group with a 67% and 65% first day pop, respectively. After disinterest earlier in the year, the IPO market is finally showing signs of strong initial deman...read more

The Trade Desk (TTD) popped 67% on Tuesday, the second-best pop from an IPO in 2016, while Novan (NOVN) took the #3 spot with a first-day pop of 65%. An impressive trade: Trade Desk up 67% The Trade Desk (TTD) surged 67% on Tuesday, giving it the year's second-best pop behind the +92% achieved by...read more

Novan, a late-stage biotech developing nitric oxide therapies for acne and other skin conditions, raised $45 million by offering 4.1 million shares at $11. It originally intended to raise $45 million by offering 3.75 million shares at a range of $11 to $13. Novan plans to list on the Nasdaq under the symbol NOVN. Piper Jaffray acted as a lead manager on the deal....read more

Nine deals are on the IPO calendar for the week ahead, aiming to raise a combined $1.2 billion. Set to be the most active week of 2016, the wave of deals counts three founder-led high-growth software companies and a telecom equipment provider. Other deals include two consumer brands, two biotechs and one bank.